Bradley Foster & Sargent’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7,933
Closed -$221K 347
2017
Q3
$221K Sell
7,933
-1,558
-16% -$46.9K 0.01% 341
2017
Q2
$303K Sell
9,491
-384
-4% -$12.2K 0.01% 303
2017
Q1
$309K Buy
9,875
+76
+0.8% +$2.33K 0.01% 300
2016
Q4
$291K Buy
+9,799
New +$299K 0.01% 297
2016
Q1
Sell
-102,743
Closed -$3.58M 337
2015
Q4
$3.58M Buy
102,743
+2,448
+2% +$81.9K 0.16% 112
2015
Q3
$3.4M Sell
100,295
-12,242
-11% -$423K 0.17% 115
2015
Q2
$3.74M Sell
112,537
-4,158
-4% -$151K 0.17% 115
2015
Q1
$4.59M Buy
116,695
+658
+0.6% +$26.4K 0.21% 105
2014
Q4
$4.65M Buy
116,037
+15,336
+15% +$609K 0.22% 104
2014
Q3
$3.64M Buy
100,701
+2,372
+2% +$89.9K 0.17% 119
2014
Q2
$3.71M Buy
98,329
+6,753
+7% +$254K 0.18% 114
2014
Q1
$3.23M Buy
91,576
+3,835
+4% +$132K 0.17% 119
2013
Q4
$2.9M Sell
87,741
-229,674
-72% -$8.19M 0.15% 122
2013
Q3
$11.8M Buy
317,415
+132,309
+71% +$5.16M 0.69% 47
2013
Q2
$7.66M Buy
+185,106
New +$8.44M 0.47% 67

Other funds holding DOC

Bradley Foster & Sargent's DOC Position: Q4 2017 in Review

Bradley Foster & Sargent sold out of Healthpeak Properties (DOC) in Q4 2017, closing a stake of 7,933 shares — an estimated $221K sold.

Bradley Foster & Sargent first reported a position in DOC in Q2 2013 and held it in 15 quarters. The position peaked at $11.8M in Q3 2013. 581 funds tracked by Wall St. Rank hold DOC as of Q4 2017.

  • Bradley Foster & Sargent reported no remaining Healthpeak Properties position as of Q4 2017 after selling out during the quarter.
  • Bradley Foster & Sargent sold 7,933 Healthpeak Properties shares in Q4 2017, an estimated $221K.
  • Bradley Foster & Sargent first reported a position in Healthpeak Properties in Q2 2013 and held it in 15 quarters.
  • Bradley Foster & Sargent's Healthpeak Properties position peaked at $11.8M in Q3 2013.
  • 581 funds tracked by Wall St. Rank held Healthpeak Properties as of Q4 2017.

Based on Bradley Foster & Sargent's 13F filing for Q4 2017, filed 6 Feb 2018.